GLPG5101
CD19
CAR-T cell therapy
Relapsed/refractory non-Hodgkin lymphoma (rrNHL)
Follicular lymphoma or marginal zone lymphoma
Mantle cell lymphoma
Diffuse large B-cell lymphoma
Our Pipeline
Focusing on high unmet medical needs, we synergize compelling science, technology, and collaborative approaches to create a deep pipeline of best-in-class small molecules, CAR-T therapies, and biologics in oncology and immunology.
Oncology
Product candidate
Target
Drug class
Indication
Discovery
Ind/cta-enabling
Phase 1
Phase 2
GLPG5201
CD19
CAR-T cell therapy
Relapsed/refractory chronic lymphocytic leukemia and Richter transformation (rrCLL/RT)
Chronic lymphocytic leukemia
Richter transformation
GLPG5301
BCMA
CAR-T cell therapy
Relapsed/refractory multiple myeloma (rrMM)
Multiple myeloma
Uza-cel*
MAGE-A4
TCR-T cell therapy
Head & neck cancer**
>5 programs
Multiple
Cell therapy
Hematological oncology and solid tumors
>5 programs
Multiple
Small molecule
Solid tumors indications
*Subject to opt-in under collaboration and exclusive license agreement with Adaptimmune for uza-cel (ADP-A2M4CD8) (signed and announced on 30 May 2024);
**Uza-cel produced on Galapagos’ decentralized manufacturing platform
Immunology
Product candidate
Target
Drug class
Indication
Discovery
Ind/cta-enabling
Phase 1
Phase 2
GLPG3667
TYK2
Small molecule
Systemic lupus erythematosus (SLE)
Systemic lupus erythematosus
Dermatomyositis
>5 programs
Multiple
Small molecule
Inflammation/auto-immune
Visit our Clinical Trials Portal
Clinical trials are a critical part of our journey to evaluate investigational treatments and gain approval from health authorities such as the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
At Galapagos, we organize clinical trials in various therapeutic areas, conducting research that paves the way for innovative solutions.
Visit our Clinical Trials portal to explore the fascinating world of clinical trials. Discover how they’re set up and gain insight into what’s important when considering participation.
Our stories
More about our company, science and people
We curate a series of inspiring stories about how we are #LivingInnovation at Galapagos
Partnerships
Work with us!
We are adding new capabilities, technologies and product candidates through internal and external innovation. Let’s start #PioneeringForPatients, together!
Investor Hub
All information for investors…
… centralized in one Investor Hub. Discover how we aim to create value for all our stakeholders.